United States - English - NLM (National Library of Medicine)

rising pharmaceuticals, inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast tablets are contraindicated in patients with hepatic impairment including hepatic cirrhosis. the safety of zafirlukast tablets at doses of 10 mg twice daily has been demonstrated in 205 pediatric patients 5 through 11 years of age in placebo-controlled trials lasting up to six weeks and with 179 patients in this age range participating in 52 weeks of treatment in an open label extension. the effectiveness of zafirlukast tablets for the prophylaxis and chronic treatment of asthma in pediatric patients 5 through 11 years of age is based on an extrapolation of the demonstrated efficacy of zafirlukast tablets in adults with asthma and the likelihood that the disease course, and pathophysiology and the drug’s effect are substantially similar betw

United States - English - NLM (National Library of Medicine)

avpak - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients.

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

american health packaging - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast tablets are contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

dr. reddys laboratories limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast tablets are contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

carilion materials management - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients.

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

strides pharma science limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

avkare - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.